Physicians’ opposition even with extension of indications on ‘Daklinza’

Medical personnel have expressed opposition to the fact that the indication for genotype 2 was excluded from ‘Daklinza(generic name: daclatasvir)’ during the process of extending indications.

Recently, the Ministry of Food and Drug Safety approved to change the Daklinza’s indication from ‘treatment of chronic hepatitis C genotype 1b in combination with other drugs for adult patients having vic...